{
    "ticker": "EVFM",
    "name": "Evolus, Inc.",
    "description": "Evolus, Inc. is a performance beauty company that focuses on delivering innovative aesthetic products for the global market. Founded in 2012 and headquartered in Newport Beach, California, Evolus is dedicated to providing non-surgical aesthetic treatments that empower individuals to express their unique beauty. The company's flagship product, Jeuveau, is an injectable neuromodulator specifically designed for aesthetic use, providing a non-invasive option for reducing the appearance of fine lines and wrinkles. Evolus is committed to enhancing the customer experience through effective marketing strategies and a strong emphasis on consumer education. With the mission to make beauty accessible and to promote self-confidence, Evolus aims to disrupt the aesthetic marketplace by providing high-quality products at competitive prices. The company continues to expand its portfolio with innovative solutions that cater to the evolving needs of consumers, backed by a robust clinical development program. Evolus is also focused on building a strong brand presence and fostering relationships with healthcare professionals to ensure successful product adoption and patient satisfaction.",
    "industry": [
        "Pharmaceuticals",
        "Aesthetic Medicine"
    ],
    "headquarters": "Newport Beach, California, USA",
    "founded": "2012",
    "website": "https://www.evolus.com",
    "ceo": "David Moatazedi",
    "social_media": {
        "twitter": "https://twitter.com/evolusbeauty",
        "linkedin": "https://www.linkedin.com/company/evolus/",
        "instagram": "https://www.instagram.com/evolusbeauty/"
    },
    "investor_relations": "https://investors.evolus.com",
    "key_executives": [
        {
            "name": "David Moatazedi",
            "position": "CEO"
        },
        {
            "name": "Frank B. F. M. H. H. D. R. M. Z. Z. T. R. T. J. R.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Injectable Treatments",
            "products": [
                "Jeuveau"
            ]
        }
    ],
    "seo": {
        "meta_title": "Evolus, Inc. | Innovative Aesthetic Solutions",
        "meta_description": "Explore Evolus, Inc., a leader in the aesthetics industry, offering innovative products like Jeuveau for non-surgical beauty enhancements.",
        "keywords": [
            "Evolus",
            "Aesthetics",
            "Beauty",
            "Injectables",
            "Jeuveau"
        ]
    },
    "faq": [
        {
            "question": "What is Evolus known for?",
            "answer": "Evolus is known for its innovative aesthetic products, particularly Jeuveau, an injectable neuromodulator."
        },
        {
            "question": "Who is the CEO of Evolus?",
            "answer": "David Moatazedi is the CEO of Evolus, Inc."
        },
        {
            "question": "Where is Evolus headquartered?",
            "answer": "Evolus is headquartered in Newport Beach, California, USA."
        },
        {
            "question": "What are Evolus's main products?",
            "answer": "Evolus's main product is Jeuveau, an injectable treatment for fine lines and wrinkles."
        },
        {
            "question": "When was Evolus founded?",
            "answer": "Evolus was founded in 2012."
        }
    ],
    "competitors": [
        "PRLB",
        "HZO",
        "HUM",
        "HRTG"
    ],
    "related_stocks": [
        "ABT",
        "PFE",
        "JNJ",
        "MRK"
    ]
}